Streetbeat News

USPH

U.S. Physical Therapy, Inc.

https://www.usph.com

Industry

Medical - Care Facilities

U.S. Physical Therapy, Inc., through its subsidiaries, operates outpatient physical therapy clinics that provide pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries. It operates through two segments, Physical Therapy Operations and Industrial Injury Prevention Services. The company offers industrial injury prevention services, including onsite injury prevention and rehabilitation, performance optimization, post-offer employment testing, functional capacity evaluations, and ergonomic assessments through physical therapists and specialized certified athletic trainers for Fortune 500 companies, and other clients comprising insurers and their contractors. As of December 31, 2021, it operated 591 clinics in 39 states; and managed 35 physical therapy practice facilities. The company was founded in 1990 and is based in Houston, Texas.

Open

90.00

Mkt cap

1.4B

Volume

115K

High

90.60

P/E Ratio

102.20

52-wk high

113.63

Low

88.83

Div yield

0.02

52-wk low

76.18

U.S. Physical Therapy, Inc. (USPH) held its Q3 2024 earnings conference call on November 6, 2024. Key company executives, including CEO Chris Reading and CFO Carey Hendrickson, participated in the call. Analysts from Jefferies, Bank of America, CJS Securities, and Barrington Research were also present.

Portfolio Pulse from

November 06, 2024 | 7:15 pm

U.S. Physical Therapy (USPH) reported Q3 earnings of $0.69 per share, surpassing the Zacks Consensus Estimate of $0.68 and improving from $0.62 a year ago.

Portfolio Pulse from

November 06, 2024 | 12:45 am

Barrington Research has reiterated its 'Outperform' rating for US Physical Therapy (NYSE:USPH) with a maintained price target of $108, indicating confidence in the company's future performance.

Portfolio Pulse from Benzinga Newsdesk

October 09, 2024 | 4:15 pm

U.S. Physical Therapy, Inc. (NYSE:USPH) has signed an agreement to acquire a 50% equity interest in a management services organization that manages 50 physical therapy clinics, primarily in New York. The transaction is expected to close on October 31, 2024.

Portfolio Pulse from Benzinga Newsdesk

October 07, 2024 | 8:07 pm

Stocks fell as oil prices surged and 10-year yields crossed 4% due to Middle East tensions. The energy sector outperformed, with USO rising over 3%. Major indices like the S&P 500 and Dow Jones declined. Super Micro Computer Inc. surged 14% on product news, while Everest Group Ltd. and Constellation Brands Inc. faced downgrades.

Portfolio Pulse from Piero Cingari

October 07, 2024 | 6:02 pm

B of A Securities has downgraded US Physical Therapy (NYSE:USPH) from Buy to Neutral and reduced the price target from $114 to $90.

Portfolio Pulse from Benzinga Newsdesk

October 07, 2024 | 11:35 am

Barrington Research has reiterated its 'Outperform' rating for US Physical Therapy (NYSE:USPH) with a maintained price target of $108, indicating confidence in the company's future performance.

Portfolio Pulse from Benzinga Newsdesk

September 20, 2024 | 3:36 pm

The article highlights notable insider trades in three companies: Elastic, U.S. Physical Therapy, and CECO Environmental. Insider purchases can indicate confidence in a company's prospects. Elastic's director bought $1.48M worth of shares after strong earnings. U.S. Physical Therapy's director purchased shares despite downbeat earnings. CECO Environmental's director and CEO made significant purchases following a revenue guidance increase.

Portfolio Pulse from Avi Kapoor

September 04, 2024 | 11:34 am

U.S. Physical Therapy has acquired a 70% interest in a physical and hand therapy practice with eight clinics in Pennsylvania, generating approximately $5.5 million in annual revenues. The current owners retain a 30% stake.

Portfolio Pulse from Benzinga Newsdesk

September 03, 2024 | 11:34 am

RBC Capital Markets initiated coverage of Concentra Group Holdings Inc (NYSE:CON) with an Outperform rating and a price target of $33, citing its dominant market position and unique investment strategy. Concentra's trading performance has mirrored its parent company, Select Medical Holdings Corp. (NYSE:SEM). The analyst sees potential upside due to Concentra's favorable reimbursement structure compared to peers like Surgery Partners Inc (NASDAQ:SGRY) and U.S. Physical Therapy Inc (NYSE:USPH).

Portfolio Pulse from Vandana Singh

August 20, 2024 | 6:39 pm

All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.